AIM: To evaluate the predictors of 10-year survival of patients with hepatitis C recurrence. METHODS: Data from 358 patients transplanted between 1989 and 2010 in two Italian transplant centers and with evidence of hepatitis C recurrence were analyzed. A χ 2, Fisher’s exact test and Kruskal Wallis’ test were used for categorical and continuous variables, respectively. Survival analysis was performed at 10 years after transplant using the Kaplan-Meier method, and a log-rank test was used to compare groups. A p level less than 0.05 was considered significant for all tests. Multivariate analysis of the predictive role of different variables on 10-year survival was performed by a stepwise Cox logistic regression. RESULTS: The ten-year survival of the entire population was 61.2%. Five groups of patients were identified according to the virological response or lack of a response to antiviral treatment and, among those who were not treated, according to the clinical status (mild hepatitis C recurrence, “too sick to be treated” and patients with comorbidities contraindicating the treatment). While the 10-year survival of treated and untreated patients was not different (59.1% vs 64.7%, p = 0.192), patients with a sustained virological response had a higher 10-year survival rate than both the “non-responders” (84.7% vs 39.8%, p < 0.0001) and too sick to be treated (84.7% vs 0%, p < 0.0001). Sustained virological responders had a survival rate comparable to patients untreated with mild recurrence (84.7% vs 89.3%). A sustained virological response and young donor age were independent predictors of 10-year survival. CONCLUSION: Sustained virological response significantly increased long-term survival. Awaiting the interferon-free regimen global availability, antiviral treatment might be questionable in selected subjects with mild hepatitis C recurrence.

Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation / Gitto, S; Belli, Ls; Vukotic, R; Lorenzini, S; Airoldi, A; Cicero, Af; Vangeli, M; Brodosi, L; Martello Panno, A; Di Donato, R; Cescon, M; Grazi, Gl; De Carlis, L; Pinna, Ad; Bernardi, M; Andreone, P.. - In: WORLD JOURNAL OF GASTROENTEROLOGY. - ISSN 1007-9327. - 21:(2015), pp. 3912-3920. [10.3748/wjg.v21.i13.3912]

Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation

Vukotic R;Pinna AD;Bernardi M;Andreone P.
2015

Abstract

AIM: To evaluate the predictors of 10-year survival of patients with hepatitis C recurrence. METHODS: Data from 358 patients transplanted between 1989 and 2010 in two Italian transplant centers and with evidence of hepatitis C recurrence were analyzed. A χ 2, Fisher’s exact test and Kruskal Wallis’ test were used for categorical and continuous variables, respectively. Survival analysis was performed at 10 years after transplant using the Kaplan-Meier method, and a log-rank test was used to compare groups. A p level less than 0.05 was considered significant for all tests. Multivariate analysis of the predictive role of different variables on 10-year survival was performed by a stepwise Cox logistic regression. RESULTS: The ten-year survival of the entire population was 61.2%. Five groups of patients were identified according to the virological response or lack of a response to antiviral treatment and, among those who were not treated, according to the clinical status (mild hepatitis C recurrence, “too sick to be treated” and patients with comorbidities contraindicating the treatment). While the 10-year survival of treated and untreated patients was not different (59.1% vs 64.7%, p = 0.192), patients with a sustained virological response had a higher 10-year survival rate than both the “non-responders” (84.7% vs 39.8%, p < 0.0001) and too sick to be treated (84.7% vs 0%, p < 0.0001). Sustained virological responders had a survival rate comparable to patients untreated with mild recurrence (84.7% vs 89.3%). A sustained virological response and young donor age were independent predictors of 10-year survival. CONCLUSION: Sustained virological response significantly increased long-term survival. Awaiting the interferon-free regimen global availability, antiviral treatment might be questionable in selected subjects with mild hepatitis C recurrence.
2015
21
3912
3920
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation / Gitto, S; Belli, Ls; Vukotic, R; Lorenzini, S; Airoldi, A; Cicero, Af; Vangeli, M; Brodosi, L; Martello Panno, A; Di Donato, R; Cescon, M; Grazi, Gl; De Carlis, L; Pinna, Ad; Bernardi, M; Andreone, P.. - In: WORLD JOURNAL OF GASTROENTEROLOGY. - ISSN 1007-9327. - 21:(2015), pp. 3912-3920. [10.3748/wjg.v21.i13.3912]
Gitto, S; Belli, Ls; Vukotic, R; Lorenzini, S; Airoldi, A; Cicero, Af; Vangeli, M; Brodosi, L; Martello Panno, A; Di Donato, R; Cescon, M; Grazi, Gl; De Carlis, L; Pinna, Ad; Bernardi, M; Andreone, P.
File in questo prodotto:
File Dimensione Formato  
Post-OTL HCV recurrence.pdf

Accesso riservato

Dimensione 877.77 kB
Formato Adobe PDF
877.77 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1237349
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact